Treatment with insulin and/or IGF1 have been shown to protect neurons against amyloid β-induced neurotoxicity, enhancing memory performance of AD patients [26] and rodents in preclinical models of AD [27–30]. Here, IGF1 is linked to Alzheimer disease.